- Trading
- Trading
- Markets
- Markets
- Products overview
- Forex
- Commodities
- Metals
- Indices
- Shares
- Cryptocurrencies
- Treasuries
- ETFs
- Accounts
- Accounts
- Compare our accounts
- Our spreads
- Funding & withdrawals
- Volume rebates
- Open account
- Try free demo
- Platforms & tools
- Platforms & tools
- Platforms
- Platforms
- Platforms overview
- MetaTrader 4
- MetaTrader 5
- MetaTrader copy trader
- cTrader
- cTrader copy trading
- Mobile trading platforms
- GO WebTrader
- PAMM
- Premium trading tools
- Premium trading tools
- Tools overview
- VPS
- Genesis
- Education
- Education
- Resources
- Resources
- News & analysis
- Education hub
- Economic calendar
- Earnings announcements
- Courses
- Courses
- Introduction to forex
- First steps in forex
- Next steps in forex
- Help & support
- Help & support
- About
- About
- About GO Markets
- Our awards
- Sponsorships
- Client support
- Client support
- Contact us
- FAQs
- Quick support
- Trading hours
- Maintenance schedule
- Fraud and scam awareness
- Legal documents
- Trading
- Trading
- Markets
- Markets
- Products overview
- Forex
- Commodities
- Metals
- Indices
- Shares
- Cryptocurrencies
- Treasuries
- ETFs
- Accounts
- Accounts
- Compare our accounts
- Our spreads
- Funding & withdrawals
- Volume rebates
- Open account
- Try free demo
- Platforms & tools
- Platforms & tools
- Platforms
- Platforms
- Platforms overview
- MetaTrader 4
- MetaTrader 5
- MetaTrader copy trader
- cTrader
- cTrader copy trading
- Mobile trading platforms
- GO WebTrader
- PAMM
- Premium trading tools
- Premium trading tools
- Tools overview
- VPS
- Genesis
- Education
- Education
- Resources
- Resources
- News & analysis
- Education hub
- Economic calendar
- Earnings announcements
- Courses
- Courses
- Introduction to forex
- First steps in forex
- Next steps in forex
- Help & support
- Help & support
- About
- About
- About GO Markets
- Our awards
- Sponsorships
- Client support
- Client support
- Contact us
- FAQs
- Quick support
- Trading hours
- Maintenance schedule
- Fraud and scam awareness
- Legal documents
- Home
- News & Analysis
- Economic Updates
- Johnson & Johnson results beat estimates
- 1 Month -0.31%
- 3 Month -5.79%
- Year-to-date +0.82%
- 1 Year +2.39%
- Wells Fargo $195
- Morgan Stanley $174
- Citigroup $205
- Raymond James $196
- Credit Suisse $205
- Goldman Sachs $181
News & AnalysisJohnson & Johnson (JNJ) reported its latest financial results for the second quarter before the opening bell in the US on Tuesday.
The US pharmaceutical and consumer goods company reported revenue that topped the Wall Street expectations at $24.02 billion (up 3% year-over-year) vs. $23.771 billion expected.
Earnings per share reported at $2.59 per share (up 4.4% year-over-year) vs. $2.54 per share estimate.
”Our solid second quarter results across Johnson & Johnson reflect the strength and resilience of our Company’s market leadership in the midst of macroeconomic challenges,” said Joaquin Duato, CEO of the company.
”I am continually energized by the focus and passion of my Johnson & Johnson colleagues and their dedication toward delivering transformative healthcare solutions to patients and consumers around the world,” Duato concluded.
Johnson & Johnson (JNJ) chart
The stock was down by around 1% during the trading day on Tuesday at $172.37 per share.
Here is how the stock has performed in the past year:
Johnson & Johnson price targets
Johnson & Johnson is the 10th largest company in the world with a market cap of $453.99 billion.
You can trade Johnson & Johnson (JNJ) and many other stocks from the NYSE, NASDAQ, HKEX and the ASX with GO Markets as a Share CFD.
Sources: Johnson & Johnson, TradingView, MetaTrader 5, Benzinga, CompaniesMarketCap
Ready to start trading?
Disclaimer: Articles are from GO Markets analysts and contributors and are based on their independent analysis or personal experiences. Views, opinions or trading styles expressed are their own, and should not be taken as either representative of or shared by GO Markets. Advice, if any, is of a ‘general’ nature and not based on your personal objectives, financial situation or needs. Consider how appropriate the advice, if any, is to your objectives, financial situation and needs, before acting on the advice. If the advice relates to acquiring a particular financial product, you should obtain and consider the Product Disclosure Statement (PDS) and Financial Services Guide (FSG) for that product before making any decisions.
Next Article
Netflix results announced – the stock is up
Netflix Inc. (NFLX) reported its Q2 results after the closing bell in the US on Tuesday. The online streaming service company reported fairly positive results for the quarter, sending the stock price higher in the after-hours trading. The company reported revenue of $7.97 billion in Q2, narrowly missing analyst estimate of $8.026 billion. Ear...
July 20, 2022Read More >Previous Article
Market jumps on the back of weak USD and better then expected earnings
The US stock market saw one of its best days in months, as speculation swirled that the 'bottom' may be in. The indices gained their momentum from bet...
July 20, 2022Read More >News and Analysis
Join our mailing list to receive market news and monthly newsletters, delivered directly to our inbox.